Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
Members of your 2020 UMass ALS Cellucci Fund team are as dedicated today as they have ever been to raise money to support ALS research at the University of Massachusetts Medical School. Details about how they will participate in this year's virtual event to come soon.
A study by Robert H. Brown Jr., MD, DPhil, published in the journal Neurology, shows that a single transplantation of a bone marrow-derived mesenchymal stem cell treatment for amyotrophic lateral sclerosis (ALS) called NurOwn was safe and well tolerated by patients.
Read more
The goal of the UMass ALS Cellucci Fund is to create a $10 million endowment to seed the boldest research ideas in the interdisciplinary labs under the direction of Robert H. Brown Jr., DPhil, MD, one of the world's foremost authorities on amyotrophic lateral sclerosis (ALS).
